Recent works demonstrated that standard care of treatment for several tumors determine a release of bioactive factors, such as VCAM1 and CCL2, that are involved in the increased macrophages infiltration in the tumor microenvironment (Kalbasi et al., 2017; Takahashi et al., 2020). This evidence concerns the gene CCL2 and neoplasm.